Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations

Conditions:   ARID1A Gene Mutation;   ATM Gene Mutation;   ATR Gene Mutation;   Bile Duct Adenocarcinoma;   BRCA1 Gene Mutation;   BRCA2 Gene Mutation;   BRIP1 Gene Mutation;   CHEK2 Gene Mutation;   EMSY Gene Mutation;   Fanconi Anemia Complementation Group Gene Mutation;   Metast atic Bile Duct Carcinoma;   MRE11 Gene Mutation;   NBN Gene Mutation;   PALB2 Gene Mutation;   PTEN Gene Deletion;   RAD51 Gene Mutation Intervention:   Drug: Olaparib Sponsors:   Academic and Community Cancer Research United;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials